How contagious is COVID-19, and how severe is the virus for those who've caught it? Everyone wants firm numbers as schools make decisions about in-person versus remote learning, as local and state governments grapple with reopening, and as families care for sick loved ones.
COVID Alert helps us break the cycle of infection. The app can let people know of possible exposures before any symptoms appear. That way, we can take care of ourselves and protect our communities.
Cancer-related patient encounters have decreased significantly as a result of the COVID-19 pandemic, according to trends observed in the COVID and Cancer Research Network and reported in JCO: Clinical Cancer Informatics.
A clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, today announced that Canadian government agencies will contribute up to CA$4.75 million to advance Phase 1 clinical development of its vaccine candidate, DPX-COVID-19, for the prevention of COVID-19 infection caused by the novel coronavirus SARS-COV-2.
A newly completed Phase III, multicenter clinical trial has found that an immune-modulating drug can silence inflammatory disease activity in a large majority of patients with relapsing multiple sclerosis (RMS)—the most common form of the illness, in which symptoms wax and wane.
The COVID-19 pandemic will most certainly affect workspace design in the future and the medical profession is likely to see substantial change.
Lawrence Livermore National Laboratory (LLNL) researchers have increased the complexity of neuronal cultures grown on microelectrode arrays, a key step toward more accurately reproducing the cellular composition of the human brain outside the body.
No laboratory consolidation project can succeed without the support of a strong foundation.
We need your help to grow this newsletter! Please pass along the subscription link to any colleague you think would benefit from hearing about med lab news.